Unknown

Dataset Information

0

Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.


ABSTRACT: Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-1?, a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is entirely rescued by pro-angiogenic therapies. In humans, the placenta in late gestation secretes VEGF inhibitors like soluble FLT1 (sFLT1), and this is accentuated by multiple gestation and pre-eclampsia. This anti-angiogenic environment is accompanied by subclinical cardiac dysfunction, the extent of which correlates with circulating levels of sFLT1. Exogenous sFLT1 alone caused diastolic dysfunction in wild-type mice, and profound systolic dysfunction in mice lacking cardiac PGC-1?. Finally, plasma samples from women with PPCM contained abnormally high levels of sFLT1. These data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period. The data also explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of PPCM.

SUBMITTER: Patten IS 

PROVIDER: S-EPMC3356917 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-1α, a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is  ...[more]

Similar Datasets

| S-EPMC8602398 | biostudies-literature
| S-EPMC6132730 | biostudies-literature
| S-EPMC4295435 | biostudies-other
| S-EPMC3600883 | biostudies-other
| S-EPMC8352111 | biostudies-literature
| S-EPMC5529770 | biostudies-other
| S-EPMC5533034 | biostudies-literature
| S-EPMC3964190 | biostudies-literature
| S-EPMC4422973 | biostudies-literature
| S-EPMC9270586 | biostudies-literature